HMGN2
HMGN2 is a protein that in humans is encoded by the HMGN2 gene. This gene is part of the High Mobility Group Nucleosome-binding (HMGN) family, a group of proteins that play a crucial role in chromatin structure and function. HMGN proteins are known for their ability to bind specifically to the nucleosome core particle, the fundamental unit of chromatin, and influence the interaction between the DNA and histones. This interaction is vital for various genetic processes, including transcription, replication, and DNA repair.
Function
HMGN2, like other members of the HMGN family, affects the structure of chromatin by loosening the nucleosome structure, making the DNA more accessible to transcription factors and other proteins involved in DNA metabolism. This action facilitates transcription and other DNA-related processes. HMGN2 has been shown to play a role in several cellular processes, including cell proliferation, differentiation, and response to DNA damage.
Gene
The HMGN2 gene is located on chromosome 1 (1q32.1) in humans. It consists of several exons and introns, and its expression is regulated by various transcription factors and epigenetic mechanisms, including DNA methylation and histone modifications.
Clinical Significance
Alterations in the expression or function of HMGN2 have been implicated in various diseases, including cancer. Overexpression of HMGN2 has been observed in certain types of cancer, suggesting a potential role in tumorigenesis. Furthermore, HMGN2 has been studied for its potential as a biomarker for cancer diagnosis and prognosis, as well as a target for therapeutic intervention.
Research
Research on HMGN2 continues to uncover its roles in chromatin dynamics and its implications in disease. Studies have explored its function in different cellular contexts, its interaction with other proteins and DNA, and its potential as a therapeutic target. The understanding of HMGN2 and its function in chromatin biology is crucial for developing novel therapeutic strategies for diseases associated with chromatin dysfunction.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD